EXR
62
7
FSLR
66
-6
TRV
50
5
SYF
83
2
CMA
64
2
EXC
66
3
GIS
47
4
NOC
34
-6
HOG
42
3
AIZ
68
4
CL
50
3
AIV
51
3
PEG
57
4
PNW
62
5
AMG
60
3
LMT
55
6
T
68
2
STZ
40
3
SEE
63
2
KMB
48
12
EXR
62
7
FSLR
66
-6
TRV
50
5
SYF
83
2
CMA
64
2
EXC
66
3
GIS
47
4
NOC
34
-6
HOG
42
3
AIZ
68
4
CL
50
3
AIV
51
3
PEG
57
4
PNW
62
5
AMG
60
3
LMT
55
6
T
68
2
STZ
40
3
SEE
63
2
KMB
48
12
Financhill
Back

Genmab AS Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
44

GMAB
Genmab AS

Last Price:
$19.89
Seasonality Move:
7.17%

7 Day Trial

ALL ACCESS PASS

$ 7

Genmab AS Stock Forecast

  • Over the next 52 weeks, Genmab AS has on average historically risen by 42.2% based on the past 15 years of stock performance.
  • Genmab AS has risen higher in 10 of those 15 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
  • Is Genmab AS Stock Undervalued?
    The current Genmab AS [GMAB] share price is $19.88. The Score for GMAB is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • GMAB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Genmab AS Stock Go Up Next Year?

  • Over the next 52 weeks, Genmab AS has on average historically risen by 42.2% based on the past 15 years of stock performance.

Genmab AS Stock Rating

Sell
44
Genmab AS (GMAB) is a Sell

Is Genmab AS overpriced?

  • Genmab AS has risen higher in 10 of those 15 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%

Genmab AS Stock Price History

Is GMAB stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GMAB is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
Denmark
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
genmab.com

52-Week Data

52-Week High:
30.06
52-Week Low:
17.24

Prediction Charts

Market Cap:
12.3B
Price in USD:
19.88
Volume:
836.6K
Beta:
0.71

Technical Analysis

SMA50:
19.93
SMA100:
20.55
SMA200:
22.32
52-Wk Change:
-32.95%

Stock Predictions

  • Is Genmab AS stock public?
    Yes, Genmab AS is a publicly traded company.
  • What is the Genmab AS stock quote today?
    The Genmab AS stock price is 19.88 USD today.
  • How to buy Genmab AS stock online?
    You can buy Genmab AS shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-29 21.04 20.79 21.08 20.75
Apr-30 21.03 21.15 21.24 20.91
May-1 21.31 20.93 21.32 20.88
May-2 21.59 21.48 21.66 21.35
May-5 21.76 21.55 21.76 21.51
May-6 21.24 20.42 21.24 20.42
May-7 20.82 20.60 20.98 20.58
May-8 19.95 19.42 19.99 19.36
May-9 19.61 19.36 19.96 19.35
May-12 19.13 19.93 19.95 19.12
May-13 19.52 19.31 19.52 18.89
May-14 19.58 19.08 19.67 19.05
May-15 19.42 19.65 19.66 19.32
May-16 19.62 19.88 19.90 19.59

Genmab AS Earnings

Genmab AS Earnings Report: Per Share Genmab AS Earnings Q1 Q2 Q3 and Q4 last year and next year.

Genmab AS Forecast Revenue Growth

Genmab AS Stock Analysis: Historical quarterly revenues per share for Genmab AS and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.09 per share, an increase next quarter of $5.23 per share, an increase this year of $0.36 per share, and an increase next year of $0.36 per share.

* Genmab AS stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.